Stay updated on M7824 and Eribulin in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the M7824 and Eribulin in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 and Eribulin in Metastatic TNBC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:56:29.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A notice about NIH’s website and terminology transition appears above the ClinicalTrials.gov 403 error page. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:59:32.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The site footer’s revision number changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:12:59.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now presents a 403 Forbidden screen with basic HTML structure and a Home link, indicating access to the study record is blocked rather than displaying the usual content. This reflects an access or permissions issue rather than an update to the study data itself.
    Difference
    0.5%
    Check dated 2026-09-30T00:18:00.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with a basic error page. This prevents viewing the trial details and related information.
    Difference
    19%
    Check dated 2026-09-23T00:30:44.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page revision was updated to version v3.7.0, replacing the previous v3.6.6 and indicating a newer revision of the study record.
    Difference
    0.1%
    Check dated 2026-09-15T23:06:11.000Z thumbnail image

Stay in the know with updates to M7824 and Eribulin in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 and Eribulin in Metastatic TNBC Clinical Trial page.